We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
-5.85%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$35.2B
AUM Growth
-$3.94B
(-10%)
Cap. Flow
-$1.12B
Cap. Flow
% of AUM
-3.19%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
1,273
New
111
Increased
414
Reduced
514
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$63.8M |
| 2 |
Align Technology
ALGN
|
+$61.4M |
| 3 |
Stellantis
STLA
|
+$54.4M |
| 4 |
UBS Group
UBS
|
+$49.7M |
| 5 |
Republic Services
RSG
|
+$44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$73.1M |
| 2 |
IPG Photonics
IPGP
|
+$62.1M |
| 3 |
Adobe
ADBE
|
+$61.1M |
| 4 |
UnitedHealth
UNH
|
+$56.3M |
| 5 |
Apple
AAPL
|
+$54.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.86% |
| 2 | Healthcare | 17.08% |
| 3 | Financials | 11.33% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Industrials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Donnelley Financial Solutions
DFIN
$1.18B
| $1.85M | 0.01% |
55,700
-2,500
| -4% | -$89.1K |
|
802
FMC
FMC
$1.41B
| $1.84M | 0.01% |
+14,001
| New | +$1.65M |
|
803
Astrana Health
ASTH
$1.9B
| $1.84M | 0.01% |
38,000
+5,200
| +16% | +$268K |
|
804
Edgewell Personal Care
EPC
$1.23B
| $1.83M | 0.01% |
49,800
+33,900
| +213% | +$1.38M |
|
805
Seagate
STX
$176B
| $1.82M | 0.01% |
20,233
-82,900
| -80% | -$8.49M |
|
806
Hilltop Holdings
HTH
$2.23B
| $1.82M | 0.01% |
61,800
-95,500
| -61% | -$3.12M |
|
807
CEVA Inc
CEVA
$786M
| $1.81M | 0.01% |
44,500
+3,700
| +9% | +$144K |
|
808
Saic
SAIC
$5.6B
| $1.8M | 0.01% |
19,514
-25,071
| -56% | -$2.16M |
|
809
United Therapeutics
UTHR
$21.5B
| $1.79M | 0.01% |
10,000
-32,293
| -76% | -$6.15M |
|
810
Cullen/Frost Bankers
CFR
$10.1B
| $1.79M | 0.01% |
12,900
-400
| -3% | -$55.7K |
|
|
WBS
811
DELISTED
Webster Financial
WBS
| $1.78M | 0.01% |
+31,800
| New | +$1.89M |
|
812
Theravance Biopharma
TBPH
$885M
| $1.78M | 0.01% |
186,500
-4,300
| -2% | -$42.1K |
|
813
Wynn Resorts
WYNN
$8.93B
| $1.77M | 0.01% |
22,200
+11,600
| +109% | +$977K |
|
814
A10 Networks
ATEN
$1.94B
| $1.76M | 0.01% |
+126,500
| New | +$1.78M |
|
815
Bruker
BRKR
$8.49B
| $1.76M | 0.01% |
27,400
-22,800
| -45% | -$1.56M |
|
816
Zions Bancorporation
ZION
$9.92B
| $1.76M | 0.01% |
26,800
-1,000
| -4% | -$68.4K |
|
817
Gildan
GIL
$8.5B
| $1.75M | 0.01% |
46,696
-1,904
| -4% | -$74.7K |
|
818
Suncor Energy
SU
$84.1B
| $1.74M | 0.01% |
53,536
+5,801
| +12% | +$172K |
|
819
iShares US Treasury Bond ETF
GOVT
$41.3B
| $1.74M | 0.01% |
+69,985
| New | +$1.79M |
|
820
Fortune Brands Innovations
FBIN
$4.77B
| $1.73M | ﹤0.01% |
27,187
-74
| -0.3% | -$5.69K |
|
821
Marcus Corp
MCS
$843M
| $1.71M | ﹤0.01% |
96,800
-3,500
| -3% | -$61.4K |
|
|
VSTO
822
DELISTED
Vista Outdoor Inc.
VSTO
| $1.71M | ﹤0.01% |
47,900
-1,500
| -3% | -$58K |
|
823
Medpace
MEDP
$17.3B
| $1.68M | ﹤0.01% |
10,300
-49,900
| -83% | -$8.23M |
|
|
NBIS
824
Nebius Group N.V.
NBIS
$56.4B
| $1.68M | ﹤0.01% |
88,894
| – | – |
|
825
iShares Russell 2000 ETF
IWM
$76.9B
| $1.67M | ﹤0.01% |
8,147
+236
| +3% | +$48.1K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q1 2022 Portfolio in Review
As of Q1 2022, Axa held 1,273 positions worth $35.2B, down 10% from $39.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Axa withdrew a net $1.12B in Q1 2022, closing 94 positions and reducing 514 holdings. Its most notable exit was Zai Lab, an estimated $21.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Freshpet worth $30.3M.
- Axa's largest Q1 2022 buy was Freshpet: 294,939 shares worth $30.3M.
- Axa added most to Pfizer in Q1 2022, an estimated $63.8M increase.
- Axa's biggest Q1 2022 reduction was Ferrari, cutting an estimated $73.1M.
- Axa fully exited Zai Lab in Q1 2022, selling an estimated $21.3M.
- Axa's ten largest holdings make up 20% of its $35.2B portfolio in Q1 2022.
- Axa opened 111 new positions and closed 94 in Q1 2022.
- Axa's portfolio value fell 10% quarter-over-quarter to $35.2B.
Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.